Glycosylated Flavonoid Compounds as Potent CYP121 Inhibitors of Mycobacterium tuberculosis

Due to the concerning rise in the number of multiple- and prolonged-drug-resistant (MDR and XDR) Mycobacterium tuberculosis (Mtb) strains, unprecedented demand has been created to design and develop novel therapeutic drugs with higher efficacy and safety. In this study, with a focused view on implem...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajrai, Leena Hussein, Khateb, Aiah M., Alawi, Maha M., Felemban, Hashim R., Sindi, Anees A., Dwivedi, Vivek Dhar, Azhar, Esam Ibraheem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599785/
https://www.ncbi.nlm.nih.gov/pubmed/36291570
http://dx.doi.org/10.3390/biom12101356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599785/
https://www.ncbi.nlm.nih.gov/pubmed/36291570
http://dx.doi.org/10.3390/biom12101356

Ejemplares similares